Literature DB >> 16877430

Erosive vitreoretinopathy and wagner disease are caused by intronic mutations in CSPG2/Versican that result in an imbalance of splice variants.

Arijit Mukhopadhyay1, Konstantinos Nikopoulos, Alessandra Maugeri, Arjan P M de Brouwer, C Eric van Nouhuys, Camiel J F Boon, Rahat Perveen, Hester A A Zegers, Dienke Wittebol-Post, Pieter R van den Biesen, Saskia D van der Velde-Visser, Han G Brunner, Graeme C M Black, Carel B Hoyng, Frans P M Cremers.   

Abstract

PURPOSE: Linkage intervals for erosive vitreoretinopathy (ERVR) and Wagner disease previously were found to overlap at 5q14.3. In a Japanese family with Wagner disease, a CSPG2/Versican splice site mutation (c.4004-2A-->G) was recently reported that resulted in a 39-nucleotide exon 8 in-frame deletion. We investigated whether CSPG2/Versican was mutated in six Dutch families and one Chinese family with Wagner disease and in a family with ERVR.
METHODS: In all families, extensive ophthalmic examinations, haplotype analysis of the 5q14.3 region, and sequence analysis of CSPG2/Versican were performed. The effects of splice site mutations were assessed by reverse transcription-polymerase chain reaction (RT-PCR) and real-time quantitative RT-PCR (QPCR).
RESULTS: Three novel intron 7 sequence variants (c.4004-5T-->C, c.4004-5T-->A, c.4004-1G-->A) were identified in seven families. The c.4004-5T-->C variant was identified in four families with Wagner disease and a family with ERVR. The families were shown to carry the same 5q14.3 haplotype, strongly suggesting that this is a common Dutch founder variant. All three changes segregated with the disease in the respective families and were absent in 250 healthy individuals. In patients with the c.4004-5T-->A and c.4004-1G-->A variants, RT-PCR analysis of CSPG2/Versican showed activation of a cryptic splice site resulting in a 39-nt exon 8 in-frame deletion in splice variant V0. QPCR revealed a highly significant (P < 0.0001) and consistent increase of the V2 (>38-fold) and V3 (>12-fold) splice variants in all patients with intron 7 nucleotide changes and in a Chinese Wagner disease family, in which the genetic defect remains to be found.
CONCLUSIONS: Wagner disease and ERVR are allelic disorders. Seven of the eight families exhibit a variant in intron 7 of CSPG2/Versican. The conspicuous clustering of sequence variants in the splice acceptor site of intron 7 and the consistent upregulation of the V2 and V3 isoforms strongly suggest that Wagner disease and ERVR may belong to a largely overlooked group of diseases that are caused by mRNA isoform balance shifts, representing a novel disease mechanism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16877430     DOI: 10.1167/iovs.06-0141

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  28 in total

1.  RhoGDI2 suppresses lung metastasis in mice by reducing tumor versican expression and macrophage infiltration.

Authors:  Neveen Said; Marta Sanchez-Carbayo; Steven C Smith; Dan Theodorescu
Journal:  J Clin Invest       Date:  2012-03-12       Impact factor: 14.808

2.  Comparison of 12 reference genes for normalization of gene expression levels in Epstein-Barr virus-transformed lymphoblastoid cell lines and fibroblasts.

Authors:  Arjan P M de Brouwer; Hans van Bokhoven; Hannie Kremer
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

Review 3.  Extracellular matrix molecules: potential targets in pharmacotherapy.

Authors:  Hannu Järveläinen; Annele Sainio; Markku Koulu; Thomas N Wight; Risto Penttinen
Journal:  Pharmacol Rev       Date:  2009-06       Impact factor: 25.468

4.  Novel VCAN mutations and evidence for unbalanced alternative splicing in the pathogenesis of Wagner syndrome.

Authors:  Barbara Kloeckener-Gruissem; John Neidhardt; István Magyar; Henri Plauchu; Jean-Christophe Zech; Laurette Morlé; Sheila M Palmer-Smith; Moira J Macdonald; Véronique Nas; Andrew E Fry; Wolfgang Berger
Journal:  Eur J Hum Genet       Date:  2012-06-27       Impact factor: 4.246

5.  Multimodal Imaging in Wagner Syndrome.

Authors:  Akshay S Thomas; Kari Branham; Russell N Van Gelder; Stephen P Daiger; Lori S Sullivan; Sara J Bowne; John R Heckenlively; Mark E Pennesi
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2016-06-01       Impact factor: 1.300

Review 6.  The multiple, complex roles of versican and its proteolytic turnover by ADAMTS proteases during embryogenesis.

Authors:  Sumeda Nandadasa; Simon Foulcer; Suneel S Apte
Journal:  Matrix Biol       Date:  2014-01-18       Impact factor: 11.583

Review 7.  Extracellular matrix in the trabecular meshwork: intraocular pressure regulation and dysregulation in glaucoma.

Authors:  Janice A Vranka; Mary J Kelley; Ted S Acott; Kate E Keller
Journal:  Exp Eye Res       Date:  2015-04       Impact factor: 3.467

8.  Expression of a hyaluronic acid-binding proteoglycan (versican) in the cynomolgus monkey eye.

Authors:  Kensuke Tajiri; Eisuke Isizaki; Atsuko Nakaizumi; Takatoshi Kobayashi; Teruyo Kida; Hidehiro Oku; Kimitoshi Nakamura; Hiroko Kuwabara; Tsunehiko Ikeda
Journal:  Int Ophthalmol       Date:  2016-01-16       Impact factor: 2.031

9.  Mutational hot spot potential of a novel base pair mutation of the CSPG2 gene in a family with Wagner syndrome.

Authors:  Shawn M Ronan; Khanh-Nhat Tran-Viet; Erica L Burner; Ravikanth Metlapally; Cynthia A Toth; Terri L Young
Journal:  Arch Ophthalmol       Date:  2009-11

10.  Evaluation and management of pediatric rhegmatogenous retinal detachment.

Authors:  Adam S Wenick; David E Barañano
Journal:  Saudi J Ophthalmol       Date:  2012-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.